Fairhaven Wealth Management »

Revance Therapeutics shares owned by Fairhaven Wealth Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Fairhaven Wealth Management from 13F filings

Historical chart of Fairhaven Wealth Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Fairhaven Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Fairhaven Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $131k 15k 8.79